NewsBenzinga米国FDA、ドクター・レディーズの年2回投与型注射薬レナカパビルに仮承認を付与――米国外120か国でのHIV予防アクセス拡大へ前進 米国FDA、ドクター・レディーズの年2回投与型注射薬レナカパビルに仮承認を付与――米国外120か国でのHIV予防アクセス拡大へ前進 Benzinga 2026.11.02 16:52 (GMT+0) Open on Benzinga Other news Intel Shares Fall 3.3% Pre-Market After Nvidia Cuts Its Stake in the Company by 25% Bitcoin, Ether Lose Over 13% in Week as Rebound Fades NRX Pharmaceuticals Q3 EPS $(0.05) Beats $(0.21) Estimate, Sales $1.159M Miss $1.300M Estimate HUYA Q3 Adj. EPS $0.03 Up From $0.02 YoY, Sales $261.441M Up From $237.147M YoY Adam Schiff Slams Corporate Executives Over Unreturned Trump Tariff Money: ‘Companies Got Tariff Refunds, Consumers Got…’ KOSPI Closes Below 5,000 as Chip Stocks Extend Slide
Adam Schiff Slams Corporate Executives Over Unreturned Trump Tariff Money: ‘Companies Got Tariff Refunds, Consumers Got…’